共 50 条
- [41] Tamuzimod in patients with moderately-to-severely active ulcerative colitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 induction trial LANCET GASTROENTEROLOGY & HEPATOLOGY, 2025, 10 (03): : 210 - 221
- [44] Curcumin-QingDai combination for patients with active ulcerative colitis: A randomized double-blinded placebo-controlled trial JOURNAL OF CROHNS & COLITIS, 2023, 17 : 691 - 691
- [45] A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF METHYLPREDNISOLONE PULSE THERAPY IN ACTIVE RHEUMATOID DISEASE LANCET, 1982, 2 (8292): : 237 - 240
- [49] Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (01): : 28 - 37
- [50] A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MAXEPA IN STROKE PATIENTS CLINICAL RESEARCH, 1984, 32 (02): : A309 - A309